Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Experimental Neurology|October 24, 2013
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sitesM Mecha, A Feliú, F J Carrillo-Salinas, et al.
Pharmacology & Therapeutics|July 5, 2016
Microglia activation states and cannabinoid system: Therapeutic implicationsM Mecha, F J Carrillo-Salinas, A Feliú, et al.
Biochemical Pharmacology|September 2, 2018
Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosisL Mestre, F J Carrillo-Salinas, M Mecha, et al.
Neurobiology of Disease|July 16, 2013
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptorsM Mecha, A Feliú, P M Iñigo, et al.
Cell Death & Disease|June 29, 2012
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stressM Mecha, A S Torrao, L Mestre, et al.
British Journal of Pharmacology|April 11, 2015
A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosisA Feliú, M Moreno-Martet, M Mecha, et al.
Brain, Behavior, and Immunity|June 19, 2015
Endocannabinoids drive the acquisition of an alternative phenotype in microgliaM Mecha, A Feliú, F J Carrillo-Salinas, et al.
British Journal of Pharmacology|May 22, 2015
PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisL Mestre, M Redondo, F J Carrillo-Salinas, et al.
Scientific Reports|March 15, 2017
Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virusF J Carrillo-Salinas, L Mestre, M Mecha, et al.
Pageof 1